Nemiralisib Uses, Dosage, Side Effects and more
Nemiralisib is under investigation in clinical trial NCT03345407 (Dose Finding Study of Nemiralisib (GSK2269557) in Subjects With an Acute Moderate or Severe Exacerbation of Chronic Obstructive Pulmonary Disease (COPD)).
| Trade Name | Nemiralisib |
| Generic | Nemiralisib |
| Nemiralisib Other Names | Nemiralisib |
| Type | |
| Formula | C26H28N6O |
| Weight | Average: 440.551 Monoisotopic: 440.232459546 |
| Groups | Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | |
| Last Updated: | January 7, 2025 at 1:49 am |
